###### Strengths and limitations of this study

-   Employing a unique combination of cutting-edge neuroimaging techniques, the study will prospectively assess changes in the brain's functional and structural connectome related to loss of consciousness after severe traumatic brain injury (TBI).

-   The repeated assessment of functional and structural brain connectivity over the course of 1 year will reveal plastic changes in the brain's connectome that accompany clinical changes in consciousness level, providing the potential to identify reliable biomarkers of recovery from impaired consciousness.

-   A relatively large sample of patients in a subacute stage recovering from severe TBI will be studied. Considering the heterogeneity of the population of patients with TBI in regards to structural brain damage, we expect a diverse group of patients with different lesion maps.
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-   Given the longitudinal nature of the study design, not all patients included will have a full dataset mostly due to potential withdrawal from the study, death or exclusion criteria that arise during recovery.

-   Different patients may have different rehabilitation programmes and different medications, and this observational study will not control for or interfere with the clinical therapies provided at the rehabilitation ward.

Introduction {#s1}
============

According to the International Initiative for Traumatic Brain Injury Research, TBI is considered one of the most pervasive causes of disability in people under the age of 45 with an incidence of approximately 500/100.000 in Europe mostly due to road traffic accidents.[@R1] At present, disorders of consciousness (DOC) derived from TBI are identified based on the duration of post-traumatic amnesia (PTA) and duration of loss of consciousness (LOC) after brain injury, which are considered the most reliable predictors of long-term prognosis following brain injury.[@R2] However, PTA and duration of LOC are not useful as prognostic tools in the early stages after severe TBI, because information on length of amnesia and unconsciousness are not fully assessed until patients emerge from said conditions.[@R2] Thus, appropriate diagnosis and in turn prognosis remain challenging for as long as they are based on behavioural signs of consciousness from the patients.

Over the past 15 years, functional brain mapping techniques have greatly expanded our knowledge on residual brain function after severe TBI.[@R4] In particular, functional MRI (fMRI) studies have shown that some patients with severe brain injury but without behavioural signs of consciousness were able to display residual cortical processing related to aspects of speech perception and even conscious awareness, indicating a potential for recovery that otherwise would have remained unrecognised.[@R5] As a consequence, fMRI as well as other functional brain mapping techniques have attracted considerable interest as a possible tool for aiding diagnosis and prognosis particularly in patients with severe TBI and DOC.[@R7] In addition to functional brain mapping, \[^18^F\]-fluorodeoxyglucose positron emission tomography (FDG-PET), which is used to estimate the cerebral metabolic rate of glucose (CMRglc), has been used in this patient population. By the use of FDG-PET, patterns of cerebral hypometabolism have been identified in TBI patients with varying levels of consciousness, indicating that such areas are dysfunctional or dormant and that synaptic activity is below normal levels. Moreover, these patterns seem to be different between clinical states associated with DOC.[@R8] Such patterns of glucose metabolism within patients have shown unprecedented high rates of correct prognosis.[@R8]

Patients who survive severe TBI can show a transition from coma towards different clinical conditions that are associated with various levels of consciousness,[@R12] from being awake but not aware of oneself and the surroundings (vegetative state (VS)/unresponsive wakefulness syndrome (UWS)) to being awake and minimally (and not consistently) aware (minimally conscious state (MCS)). Patients can fully recover consciousness and may signal it by functionally interacting with the environment, which is referred to as emergence from MCS.[@R13] While the prognosis for patients who remain in coma is uniformly poor, prognosis for patients admitted to in-hospital rehabilitation with VS/UWS is somewhat better, and some recovery of function for patients in MCS after TBI is certainly possible.[@R14] This is especially true in the case of patients regaining consciousness within a few weeks after injury.[@R15] At present, misdiagnosis between UWS/VS and MCS can reach levels as high as 40% with standard clinical testing, which ultimately affects the clinical prognosis and rehabilitation programmes.[@R16] Strikingly, the brain connectivity changes that occur during recovery and the underlying mechanisms that result in either the emergence from or a persistent DOC are at present not understood, and no reliable biomarkers that predict recovery have yet been identified.

Two influential models define consciousness as an emergent property of the integrated behaviour of widespread cortical networks. The information integration theory of consciousness states that consciousness is secured by a large repertoire of available states in which the brain can integrate information.[@R17] According to the global neuronal workspace theory of consciousness, conscious access occurs when incoming information is made globally available to multiple brain systems through long-range cortico-cortical neuronal connections between prefrontal, parieto-temporal and cingulate cortices.[@R18] Accordingly, electroencephalography (EEG) and fMRI studies have consistently shown a degradation of long-range cortico-cortical connectivity in unconscious brain states such as sleep, anaesthesia or TBI.[@R19]

Building on previous TBI neuroimaging research, the overall aim of this longitudinal multimodal trial is to prospectively assess dynamics of cortico-cortical brain connectivity changes after TBI and to derive patterns of metrics that probe connectivity. For this purpose, a range of advanced brain mapping techniques, which do not rely on the patient\'s ability to produce behavioural responses, will be applied. Using a prospective and longitudinal study design, repeated assessment of the brain's connectivity during the subacute stage (ie, period of specialised neurorehabilitation after discharge from neurointensive care) and at 1-year follow-up will be performed. The project will aim to include the largest group of TBI patients (n=30) in the subacute stage studied so far with multiple neuroimaging modalities. Finally, strict inclusion criteria and comprehensive clinical and neuroradiological assessments will be performed in order to take into account the heterogeneity of the TBI patient group and to thoroughly characterise the anatomical lesion pattern after severe TBI. The prospective longitudinal testing of TBI patients with DOC will enable us to follow the progression associated with emerging from unconsciousness (in those patients who recover) and to trace the dynamics of cortico-cortical connectivity indices associated with recovery of consciousness. Candidate connectivity patterns that are expected to promote the re-emergence of consciousness are cortico-cortical connectivity within the default mode network and between prefrontal and parieto-temporal areas. The multimodal assessment will allow the identification of integrated cortico-cortical connectivity indices across brain mapping modalities, which we hypothesise can more reliably predict recovery from DOC as compared with currently used prognostic methods.[@R22]

Methods and analysis {#s2}
====================

Participants and timeline {#s2a}
-------------------------

We plan to prospectively include a group of 30 patients over the age of 17 in the study. Due to the multimodal nature of our experimental design, a power calculation of the required sample size that would comprise the combined different methods was not feasible. Following a pragmatic approach, the sample size was then determined based on prior longitudinal studies of connectivity in patients with severe TBI and DOC within the subacute stage where significant results were obtained (see [table 1](#T1){ref-type="table"},[@R20]). Studies that had included larger samples examined patients with heterogeneous aetiologies where only a subgroup of patients had traumatic aetiology or had patients in the subacute stage (eg, ref [@R8]), making it difficult to estimate the effect size for this specific patient population. The overall aim of the present sample size definition, thus, is to extend on the average sample size commonly reported (ie, on average about 15 patients per study) in order to account for potential dropouts, deaths and exclusions, as well as to capture the inherent heterogeneity of this patient population. Eligible participants are patients who have suffered closed-head traumatic brain injuries and are subsequently transferred to the Department of Neurorehabilitation, Traumatic Brain Injury at Rigshospitalet (Denmark), located at Hvidovre Hospital. Inclusion in the study and first measurements will take place within the first 2 weeks of admission to the unit, irrespective of the consciousness level at the moment of the inclusion (UWS/VS, MCS or higher). Further measurements will be acquired between 6 and 10 weeks after commencement of rehabilitation, at discharge (approximately 3 months after admission, although it may vary across patients due to clinical progression) and at 1-year follow-up after TBI. Furthermore, a group of 20 gender-matched, age-matched and socioeconomically matched healthy control participants will be included in the study. Healthy participants will be recruited by online and physical ads where they can get in contact with the researcher in charge of recruitment. They will undergo two measurements corresponding to the admission and the discharge time points of the patients, which will be approximately 3 months apart. For a schematic representation of the timeline, see [figure 1](#F1){ref-type="fig"}. The study protocol is registered within ClinicalTrials.gov with identifier number NCT02424656.

![Schematic representation of the timeline for the experimental sessions in relation to the clinical rehabilitation of the patients. Please note that the discharge of the patient does not have a fixed week number but can vary across patients due to clinical reasons. Consc. eva. ('Consciousness evaluation') refers to the clinical evaluation of the consciousness state of the patient via standardised clinical scales. EEG, electroencephalograph; EFA, early functional abilities; FDG-PET, \[^18^F\]-fluorodeoxyglucose positron emission tomography; FIM, functional independent measure; MRI, magnetic resonance imaging; TMS, Ttranscranial magnetic stimulation.](bmjopen-2017-016286f01){#F1}
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Sample size of neuroimaging longitudinal studies in patients in the subacute stage after severe TBI

  Authors/year                    N (longitudinal)   Method               Main finding
  ------------------------------- ------------------ -------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Venkatesan *et al* 2015[@R23]   13                 Resting-state fMRI   Hippocampus -- dorsolateral prefrontal cortex connectivity at subacute stage positively correlates with attentional performance at both subacute and chronic stages.
  Sidaros *et al* 2008[@R24]      23                 Diffusion MRI        Diffusion tensor imaging (DTI) results at the subacute stage predict outcome 1 year later.
  Sidaros *et al* 2009[@R27]      24                 Diffusion MRI        Percentage of brain volume changes at the subacute stage significantly improved prediction of long-term status as compared with clinical examination alone.
  Rosanova *et al* 2012[@R20]     5                  TMS-EEG              Changes in effective connectivity accompany changes in LOC as clinically assessed. No prediction of outcome analyses.
  Newcombe *et al* 2016[@R25]     12                 Diffusion MRI        Changes in white matter integrity significantly correlate with outcome.
  Roy *et al* 2017[@R26]          14                 Resting-state fMRI   Activation patterns within the frontal default mode network and temporal-parietal attentional control regions is a significant predictor of cognitive performance.
  Edlow *et al* 2016[@R28]        11                 Diffusion MRI        Optimal timing of DTI for TBI prognostication may be in the subacute period.
  Average                         14.5                                    

fMRI, functional MRI; LOC, loss of consciousness; TBI, traumatic brain injury; TMS-EEG, transcranial magnetic stimulation with electroencephalography.

Project workflow {#s2b}
----------------

The project will run over 5 years. The study started in summer 2013 with the recruitment of the first patients and healthy control participants in summer 2014. Recruitment is ongoing, with expected final date for patient recruitment estimated to be winter 2017--2018. Data analysis started in 2014 and will be run parallel to data acquisition until winter 2017--2018. Finally, dissemination of results and article writing will take place between 2017 and 2018. For a schematic representation of the project workflow, see [figure 2](#F2){ref-type="fig"}.

![Schematic representation of the workflow. Please notice that some steps overlap due to the requirements of the study (planning on patient recruitment cannot be made in advance since it depends on admission to the rehabilitation department). EEG, electroencephalography; dMRI, diffusion Mangentic resonance imaging; fMRI, functional magnetic resonance imaging; PET, positron emission tomography; MR, Magnetic resonance; TMS, transcranial magnetic stimulation.](bmjopen-2017-016286f02){#F2}

Experimental design {#s2c}
-------------------

Each assessment will be divided in three experimental sessions: an MRI session, a session combining TMS with EEG (performed on consecutive days) and a session of FDG-PET. Moreover, clinical evaluation of DOC will be measured by the Coma Recovery Scale-Revised[@R29] and the Rancho Los Amigos Scale.[@R30] Functional ability will be measured by the Functional Independent Measure[@R31], and the Early Functional Abilities Scale[@R32] will be performed once a week during admission and at follow-up.Behavioural and clinical assessments. At the time of admission detailed information about demographics, mechanism of injury, neurological deficits, injury severity, acute complications and length of acute treatment will be collected according to a standard protocol. The level of consciousness[@R29] and length of PTA[@R34] will be prospectively assessed with validated scales by trained personnel. Clinical evaluation will include complications (epilepsy, hydrocephalus and pneumonia) and activities of daily living whenever possible.MRI protocol. Using an echo-planar imaging (EPI) sequence (gradient echo EPI, repetition time TR=2150 ms, echo time TE=26 ms, GRAPPA acceleration factor 2, flip angle 78°, 42 axial 3 mm slices without gap, 192 mm field of view (FOV), 3 mm isotropic resolution, 32-channel head coil), whole-brain fMRI will be performed during a 10 min period of rest with eyes open (resting-state fMRI) (rs-fMRI)) with concurrent EEG (MR-compatible 32-channel EEG cap (EasyCap, Germany) and an online EEG recording system (Brain Vision Recorder, Brain Products, Germany). Due to the differences in brain networks as measured with rs-fMRI between wakefulness and sleep, patients will be maintained awake by a trained nurse using standard clinical procedures. Whole-brain structural images will be acquired to assess macrostructural damage including bleedings. Structural images will comprise of T1-weighted imaging, T2-weighted imaging, fluid-attenuated inversion recovery and susceptibility-weighted imaging, and lesion maps will be delineated for parcellation of each individual brain. Diffusion MRI (dMRI) will cover the whole brain with 61 directions and a 2.3 mm^3^ isotropic resolution.[@R35] A b value of 1000 s/mm^2^ will be used for the dMRI sequence from which tractography measures will be derived. A b value of 2000 s/mm^2^ and 500 s/mm^2^ (with six directions) will be furthermore used for the analysis of Neurite Orientation Dispersion and Density imaging (NODDI), used to derive measures of microstructural white matter integrity.[@R36] MRI measurements will be performed on a 3 Tesla whole-body MR Siemens scanner (Magnetom VERIO, Siemens Healthcare, Germany) using a 32-channel head coil. The full scanning session will last approximately 1 hour and 30 min.EEG with and without concurrent TMS. EEG will be recorded using a TMS-compatible 64-channel EEG system (EasyCap and BrainProducts, Germany). TMS will be applied using a small figure-of-eight coil (50 mm wing diameter) and a magnetic stimulator (Mag&More, Germany). Stereotactic neuronavigation (LOCALITE, Germany) will be performed with the individual T1-weighted MR images of the patients, in order to ensure anatomically sensitive placement of the hotspots and to avoid areas with lesions. The location of the EEG electrodes will be recorded with the neuronavigation system, as an overlay on the three-dimensional-rendered brain surface. The EEG electrode locations will be kept the same across measurements to ensure same spot of cortical stimulation and to minimise the variability of source localisation across sessions. EEG will be recorded during a 10 min period during which patients will rest with eyes open (resting-state EEG, same procedure as for rs-fMRI) at the beginning and at the end of the experiment. TMS-evoked cortical responses, applied over the posterior parietal and superior frontal cortices, will be recorded according to the protocol described by Rosanova *et al*.[@R20] Moreover, a sham condition using concurrent somatosensory and auditory stimulation (as previously done in ref [@R37]) will be performed, in order to control for the effects of multisensory stimulation on the EEG-evoked responses.FDG-PET studies are acquired with Siemens Biograph mCT 128 4R (Siemens Healthcare, Germany). Forty minutes after intravenous injection of 200 MBq (±10%) ^18^F-FDG a venous blood sample is drawn to measure plasma glucose level and tracer concentration. Subsequently, a low-dose CT scan (for attenuation correction) followed by a 10 min PET scan is obtained. An arterial input function will be estimated by scaling a standardised arterial input function[@R38] and CMRglc quantified using Sokoloff's autoradiographic method.[@R39] All patients will be fasting 6 hours prior to the FDG-PET scan, and exercise is restricted. Due to differences in FDG-PET results between wakefulness and sleep, patients will be maintained awake by a trained nurse using standard clinical procedures for 30 min postinjection while lying in a quiet room with covered eyes.

Data analysis {#s2d}
-------------

Structural MR images will be analysed using statistical parametric mapping software (SPM12 Wellcome Centre of Imaging Neuroscience, Institute of Neurology, UCL, London, UK; <http://www.fil.ion.ucl.ac.uk/spm>) with the packages for voxel-based cortical thickness and for voxel-based morphometry (Computational Anatomy Toolbox 12). For the rs-fMRI data, graph-theoretical methods will be used for characterising information processing in complex networks. In particular, we will generate functional graphs by correlating mean BOLD signals in parcellated cortical and subcortical regions, using the Desikan-Killiany Atlas implemented in FreeSurfer[@R40] and derive measures of network efficiency[@R41] for each subject. In addition, we will use group independent component analysis (GIFT software package <http://mialab.mrn.org/software>), to estimate each subject's expression of the default mode network. For the EEG analyses, detrended fluctuation analysis (DFA) for the resting state will be performed in accordance to the workflow set out by Hardstone *et al*.[@R42] DFA measures the degree of long-range temporal correlations in the amplitude envelope in different frequency bands by estimating the so-called scaling exponent, which is expected to increase with increasing level of consciousness due to the hypothesised restoration of cortico-cortical connectivity alongside recovery.[@R20] For the TMS-EEG data, in-house scripts as well as Fieldtrip (fieldtrip.fcdonders.nl), running in Matlab (MathWorks), will be used for the analysis of TMS-evoked potentials. TMS-EEG effective connectivity will be analysed according to the methods described in Rosanova *et al*.[@R20] Data analysis of FDG-PET scan for measuring CMRglc will be performed using PMOD software (PMOD Technologies, Zürich, Switzerland). dMRI data will be processed and analysed using the diffusion toolbox of the FSL software package (<http://www.fmrib.ox.ac.uk/fsl>). Furthermore, a new method called anatomical connectivity mapping (ACM), used to obtain a measure of anatomical connectivity for each voxel in the brain,[@R43] will be used. AMICO[@R44] (<https://github.com/daducci/AMICO>) will be used for the analysis of NODDI. Finally, in order to assess the advantages of obtaining data from multiple modalities in characterisation and prediction of outcomes, we will form multivariate classification and regression models based on multiple modalities. This approach will be based on machine learning and resampling techniques for assessing prediction performance in estimating the clinical evaluation of DOC and recovery from DOC. We will rely on Gaussian process regression, which has as an advantage that regularisation parameters to avoid over-fitting can be identified by a computationally efficient Bayesian learning procedure. This avoids the need for an additional cross-validation procedure to identify regularisation parameters. Due to the relatively low number of data samples, we will perform leave-one-out cross-validation to estimate the unbiased prediction performance. The data dimensionality will be kept low and we will include features from the different modalities, which reflect our prior hypothesis (see below) that the structural and functional long-range connectivity is predictive of level of consciousness.

Expected results {#s2e}
----------------

### Overall hypotheses {#s2e1}

The main overarching hypothesis is that residual structural and functional connectivity of long-range cortico-cortical neurons connecting prefrontal-parieto-temporal and cingulate cortices is a major determinant for recovery of consciousness after severe TBI.

Moreover, we hypothesise that the multimodal assessment will enable to identify integrated cortico-cortical connectivity indices across brain mapping modalities, which are associated with recovery from DOC. More specifically, by integrating multiple brain mapping modalities (diffusion and fMRI, online fMRI and EEG, online TMS-EEG, TMS-EEG and diffusion, and TMS-EEG and structural MRI), this study will provide unprecedented insights in how severe TBI alters the brain's 'connectome'. These integrated cortico-cortical connectivity indices may help to predict the probability to recover consciousness and increase prognostic power.

### Specific hypotheses {#s2e2}

A set of specific hypotheses will be tested with this project, which will depend on the type of research technique applied:*Resting-state EEG and fMRI measurements.* Impaired resting-state cortico-cortical connectivity in the 'Default Mode Network' (a set of interconnected areas that show activation during internal tasks such as daydreaming; see, eg, ref[@R45]) will be expected, with connectivity of parietal areas being critical for the re-emergence of minimal consciousness.[@R46] In addition, we expect that the increase in the level of consciousness is related to an increase in network efficiency as reflected by the average shortest path length.[@R47] The resting-state EEG is characterised by oscillations with characteristic fluctuations in frequency and amplitude over time. Amplitude fluctuations of alpha and beta oscillations exhibit long-range temporal correlations that can be investigated using detrended fluctuation analysis (DFA[@R48]). DFA exponents of amplitude fluctuations in the alpha and beta frequency bands of the resting-state EEG are expected to be low (\~0.6) in the lowest levels of consciousness and increase (\>0.7) with increasing levels of consciousness. We hypothesise that this reflects increasing levels of complexity of the temporal structure of brain oscillations when recovering from DOC.*Functional cortical reactivity (measured with TMS-EEG).* Recently, Rosanova and colleagues have shown in 12 chronic TBI patients that TMS-EEG measures of effective connectivity could reliably discriminate between unconscious (UWS) and minimally concious (MCS) patients.[@R20] In UWS, focal TMS triggered only a simple, local response, indicating a breakdown of effective connectivity to remote cortical regions as previously demonstrated in the unconscious state of sleep.[@R52] In MCS, in contrast, TMS triggered complex activations that sequentially involved remote cortical areas that were more similar to healthy subjects during wakefulness. Longitudinal TMS-EEG measurements during gradual recovery of consciousness in a small group of patients (n=5) revealed a re-establishment of long-range cortical connectivity before behavioural correlates of consciousness re-emerged.[@R20] Thus, we hypothesise that residual cortico-cortical effective connectivity will be revealed as an important neural basis for the recovery of consciousness.*Structural integrity of white-matter pathways (assessed with dMRI).* A recent dMRI study showed that structural integrity of white-matter pathways in the default mode network inversely correlated with impairment of consciousness.[@R53] Hence, dMRI may help to estimate the potential of the brain to regain consciousness after severe TBI, as this might depend on the extent of axonal damage in long-range cortico-cortical pathways. Thus, we hypothesise that the overall impairment of long-range cortico-cortical connectivity, as assessed with ACM, will be a strong predictor for the recovery of consciousness. ACM is less dependent on the exact location of the structural damage,[@R54] as it reflects integrated damage along a tract system, and is therefore particularly well suited when comparing patients with diffuse structural damages.*Cerebral glucose metabolism (assessed with FDG-PET).* Improvement of CMRglc within the bilateral frontoparietal network and medial temporoparietal areas (precuneus and Broca's area) at the cortical level, as well as within the thalamus and cingulate cortex at the subcortical level,[@R8] during subacute rehabilitation will correlate with increases in the level of consciousness as opposed to a persistent lower level of consciousness. Furthermore, we hypothesise that the degree of reduced CMRglc in the subacute state and at 1-year follow-up is a strong predictor for recovery of consciousness and related to cognitive function.

Ethics and dissemination {#s3}
========================

The project has received ethical approval by the local ethics committee of the Capital Region of Denmark no. H-4-2013-186 and by the Danish Data Protection no GLO-2014--49/I-Suite number 03 389 (valid until 31 October 2020). A specialised nurse will be present for all the measurements performed on the patients, and a physician will be either present or on call for all the sessions. Any adverse events will be reported to the ethics committee as required by standard protocol. In the early stages of the study, informed consent will be obtained from both the proxy and the patient's general practitioner, a judicial procedure that is required by Danish law. For similar reasons, it is mandatory to obtain informed consent from the included patients as soon as they are capable to reliably perceive and understand information themselves about the purpose of the project, side effects and discomfort associated with the procedures. However, none of the measurements are known to have any adverse impact on either healthy participants or patients with neurological disorders.

In the last 5 years, a range of neuroimaging methods has been successfully used to capture the neural correlates of recovery of consciousness after severe TBI.[@R56] Existing data indicate that the residual structural and functional connectivity of long-range cortico-cortical neurons connecting prefrontal-parieto-temporal and cingulate cortices is a major determinant for the recovery of consciousness after severe TBI. While previous brain mapping studies have undoubtedly provided valuable new insights into the neural underpinnings of impaired consciousness in TBI patients, they also have inherent limitations. For example, most studies were carried out in chronic rather than acute or subacute TBI patients with DOC. Those few studies, which have prospectively assessed effective cortico-cortical connectivity, included only very small groups of acute or subacute TBI (n\<10) and only used a single functional brain mapping modality in most cases, with recent exceptions.[@R57] Moreover, most of the studies did not relate their findings to the underlying changes in structural brain connectivity as measured with dMRI or glucose metabolism as measured with FDG-PET.[@R4] Finally, characterisation of patients in terms of the neuroanatomical lesion pattern was usually poor, and the considerable interindividual variation in TBI-induced brain damage was not taken into account when evaluating the link between cortico-cortical connectivity and consciousness.[@R58]

The present study is highly original in two ways: (1) it will use a unique cohort of patients with TBI, possibly including the biggest sample of TBI patients that has ever been studied prospectively starting in the immediate subacute phase with multiple assessments during the first year of recovery, and (2) it will acquire and integrate connectivity data obtained with a unique combination of cutting-edge brain mapping techniques. Under the main hypothesis of the inherent correlation between multimodal brain imaging data measuring brain functional and neuroanatomical changes in DOC, this novel combination of neuroimaging techniques will dramatically improve the overall picture of the evolution of consciousness in TBI patients. Moreover, it will give a much finer and precise perspective of potential markers predicting the outcome in DOC derived from the combination of multidimensional functional and anatomical consciousness correlates. In addition, the data will shed light on the more basic understanding of the neural mechanisms behind consciousness. This rich multimodal dataset will moreover be used to significantly extend previously established brain connectivity metrics that are associated with the re-emergence of consciousness employing multivariate statistical analysis.

Considering that some degree of disordered consciousness is a cardinal symptom among patients with severe TBI, this comprehensive and prospective examination of how patients regain a conscious state will shed substantial new light on the anatomical and functional underpinnings of re-emergence of consciousness after severe TBI. The high incidence of TBI in Europe calls for an extensive research on the determinants influencing TBI recovery to take place as soon as possible. The recent advancements on multimodal combination of brain stimulation and imaging techniques[@R60] present the opportunity to gather a much needed overall picture of the neural underpinnings of recovery of consciousness in patients with TBI.

The results will have considerable societal relevance, being highly connected to the neurorehabilitation of patients with TBI and their families and in turn to a better monitoring and prediction of recovery. The results may also lead to valuable neuroimaging biomarkers that can be used to assess the efficacy of consciousness-enhancing therapeutic interventions, for example, new pharmaceutical treatments, and will be reported as original research articles in peer-reviewed journals as well as in international conferences. Publications will follow open-access policies in order to increase the extent of the results outreach. Moreover, group data of brain activation maps will be made available at the public repository NeuroVault (<http://www.neurovault.org/>). Due to the data protection agreement, as well as ethical consent restrictions, individual data will not be made publicly accessible.
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